资讯

WKRG27 天
Biocon Biologics Announces U.S. FDA Approval for Jobevne™, Biosimilar Bevacizumab ...
BRIDGEWATER, N.J. and BENGALURU, India, April 10, 2025 /PRNewswire/ --Biocon Biologics Ltd (BBL), a subsidiary of Biocon Ltd (BSE code: 532523, NSE: BIOCON), today ...
The New Indian Express22 天
Biocon shares jump 4 per cent after subsidiary secures US market entry for Yesafili
BENGALURU: Biopharmaceutical company Biocon's share price on Tuesday jumped over 4 per cent after its subsidiary Biocon Biologics Ltd (BBL) announced its settlement and licence agreement with ...